4th Quarter - Report

BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

Firm
Client
Income
—
Expenses
$135,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues pertaining to access to quality care for blood cancer patients [HR 460, Patients Access to Treatments Act - all provisions]; [HR 1801, The Cancer Drug Coverage Parity Act - all provisions]; [HR 2827, The Part D Beneficiary Appeals Fairness Act - all provisions]; [P.L. 111-148, the Patient Protection and Affordable Care Act - provisions specific to Medicaid and end of life issues]

LobbyistCovered position, as disclosed
DIANA CHRISTIAN —
EMILY SHETTY Legislative Director, Rep. Edolphus Towns

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1801 (113th), H.R. 2827 (113th), H.R. 460 (113th)

Budget/Appropriations BUD

Issues pertaining to the FDA drug approval process and agency funding - [HR 2725, the FDA Safety Over Sequestration Act]; Issues pertaining to funding for the National Center for the Advancement of Translational Sciences and the National Institutes of Health, specifically for pediatric and general cancer research - [FY14 Labor Health and Human Services and Related Agencies subcommittee bill - provisions related to NCATS & NIH]

LobbyistCovered position, as disclosed
DIANA CHRISTIAN —
EMILY SHETTY Legislative Director, Rep. Edolphus Towns

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2725 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.